Another R&D Deal For Takeda As It Inks Parkinson’s Alliance
This article was originally published in PharmAsia News
Executive Summary
Deals and R&D partnerships are coming thick and fast for Takeda in the first few days of the year, with the major Japanese firm unveiling a new tie-up with NsGene to progress direct-delivered cell therapies for Parkinson's disease.